NFKB1 and Hodgkins lymphoma: Our data demonstrate for the first time a novel CK2 mediated regulation of PD-L1 (CD274) in HL, since CK2 chemical inhibition with CX-4945 leads to the downregulation of PD-L1, possibly mediated through the impairment of STAT3 and NF-κB transcriptional activity.